Cytori Therapeutics

Developing and commercializing cell therapies and nanomedicines for significant unmet medical and market needs.

[Cytori Therapeutics @Cytori]

Cytori Will Become Plus Therapeutics, Inc. https://t.co/X6bIsE41b0
#nanotechnology #oncology #pharmaceuticals #cancertreatment
$CYTX @plustxinc

[Cytori Therapeutics @Cytori]

Cytori's new Japanese website is now live!
https://t.co/6e2DysziO1 #CellTherapy #RegenerativeMedicine

[Cytori Therapeutics @Cytori]

Cytori Files Pre-submission Request for New Drug Application (Doxorubicin Hydrochloride Cytori - First Intended for European Market) #nanomedicine https://t.co/9XIqE2zlza

[Cytori Therapeutics @Cytori]

Cytori Cell Therapy™ Clinical Trial Results in Crohn’s Disease https://t.co/uqqYMrHSkD $CYTX #CellTherapy #Nanomedicine

[Cytori Therapeutics @Cytori]

https://t.co/aVcOYdNGXD $CYTX

[Cytori Therapeutics @Cytori]

Cytori Announces Japan Class III Medical Device Approval for Cell Therapy Product https://t.co/OkQkxz3vrr $CYTX #celltherapy #nanomedicine

[Cytori Therapeutics @Cytori]

Cytori Reports Q3 2018 Business and Financial Results https://t.co/F1awnfxC7f $CYTX #nanomedicine #celltherapy

[Cytori Therapeutics @Cytori]

Cytori to Webcast Third Quarter Financial Results on November 14 https://t.co/SjagKebP7j $CYTX #celltherapy #nanomedicine

[Cytori Therapeutics @Cytori]

Cytori Therapeutics Announces Receipt of Puregraft® Royalty Milestone https://t.co/Ypt6ih8wXz $CYTX

[Cytori Therapeutics @Cytori]

Cytori's Phase 2 Ready Oncology Drug Receives FDA Orphan Drug Designation https://t.co/T8TSNpc5ZB @theNCI #lungcancer $CYTX

[Cytori Therapeutics @Cytori]

Cytori President/CEO, Marc Hedrick MD, to present "Adult Adipose Cell Therapy for Inflammatory Conditions" at the 6th Annual Midwest Conference on Cell Therapy and Regenerative Medicine https://t.co/0GF47PDhEL $CYTX

[Cytori Therapeutics @Cytori]

Cytori Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference https://t.co/cHf57Pczsx $CYTX

[Cytori Therapeutics @Cytori]

Cytori Reports Q2 2018 Business and Financial Results $CYTX https://t.co/FZzPPk7i3D

[Cytori Therapeutics @Cytori]

Cytori Reports Publication of Interim Pilot Data for Cell Therapy in Vocal Fold Scarring https://t.co/V10G12SfSs $CYTX

[Cytori Therapeutics @Cytori]

Cytori to Webcast Second Quarter Financial Results on August 14 $CYTX
https://t.co/lub5xsODNZ

[Cytori Therapeutics @Cytori]

Cytori Reports Sustained Benefit of Cell Therapy in #ErectileDysfunction Trial $CYTX #Urology #ProstateCancer @MensHealthMag https://t.co/xYIJ0P4KvE

[Cytori Therapeutics @Cytori]

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study $CYTX
https://t.co/8x73rs9cCg

[Cytori Therapeutics @Cytori]

Cytori Reports Q1 2018 Business and Financial Results $CYTX https://t.co/e6xXqyksF2

[Cytori Therapeutics @Cytori]

https://t.co/UzCmfPPjeL What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease $CYTX

[Cytori Therapeutics @Cytori]

https://t.co/6p3F33fbkn Risk Versus Reward: The Value of #CellTherapy for Patients and Investors $CYTX